Laparoscopic Ethanol Sclerotherapy for Ovarian Endometriomas: Preliminary Results.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
Historique:
received: 30 05 2019
revised: 30 08 2019
accepted: 06 09 2019
pubmed: 8 5 2020
medline: 2 2 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

The purpose of this study was to evaluate the laparoscopic aspiration of endometriomas through 95% ethanol sclerotherapy. A single-center, retrospective study. Endometriosis outpatient clinic of a tertiary university hospital, gynecology department of Agostino Gemelli University Foundation Polyclinic IRCCS, Rome, Italy. Fifty-three women with 64 identified endometriomas measuring 4 to 10 cm with no suspected malignancy. Laparoscopic aspiration and 95% ethanol sclerotherapy of endometriomas were completed in the patients between September 2013 and September 2017. Using standard laparoscopy, the ovarian endometriomas were aspirated and washed to remove all cystic material. A 95% ethanol solution was instilled in the cysts and left for 15 minutes, then removed. The patients were followed by ultrasound at 3, 6, 9, and 12 months, and then annually to identify recurrence. All patients were administered postoperative hormone therapy, suspended only in those desiring pregnancy or experiencing adverse effects. The mean age was 32 years (range 19-40 years), and the mean cyst diameter was 6 cm (range 4-10 cm). Thirteen of the 53 patients (25%) had had previous surgery for endometriomas. Forty-one patients (77%) had associated deep endometriosis, treated during the same laparoscopic procedure. No major ethanol-related complications were recorded. The mean length of follow-up was 31 months. Recurrence of endometriomas was observed in 5 patients (9%). Overall, pregnancy occurred in 16 of 28 patients (57%) desiring pregnancy. Laparoscopic aspiration and ethanol sclerotherapy as treatment for endometriomas, even in patients with bilateral endometriomas or with associated deep endometriosis, resulted in <10% recurrence and no major complications.

Identifiants

pubmed: 32380241
pii: S1553-4650(20)30224-7
doi: 10.1016/j.jmig.2019.09.792
pii:
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1331-1336

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Alessandra De Cicco Nardone (A)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy. Electronic address: alessandradecicco@gmail.com.

Pietro Carfagna (P)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy.

Carlo De Cicco Nardone (C)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy.

Giovanni Scambia (G)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy.

Riccardo Marana (R)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy.

Fiorenzo De Cicco Nardone (F)

Department of Women's Health Sciences and Children's and Public Health, Agostino Gemelli University Foundation Polyclinic IRCCS (Drs. A. Nardone, Carfagna, Scambia, Marana, and F. Nardone); Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome (Dr. C. Nardone), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH